(June 9, 2021) - “Penn’s Gene Therapy Program substantially expanded its life science research capacity after signing a foundational lease with Discovery Labs, a company that leases biopharma space for life science research, on May 25.
For nearly three decades, GTP has made a name for itself in the scientific community by developing novel vector technologies for gene therapy. GTP is also affiliated with the Orphan Disease Center, which uses translational research to develop therapies for rare diseases. Through their multi-year deal with Discovery Labs, GTP has become an anchor tenant in their recently-erected one-million-square-foot campus in King of Prussia, Pennsylvania.”
Read full story